Get complete Patent Opposition Report for Cytokinetics

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Cytokinetics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3999180May 8, 2024Polymorphs Of (R)-N-(5-(5-Ethyl-1,2,4-Oxadiazol-3-Yl)-2,3-Dihydro-1H-Inden-1-Yl)-1-Methyl-1H-Pyrazole-4-Carboxamide1
EP2970123Aug 14, 2019Salt Of Omecamtiv Mecarbil And Process For Preparing Salt1